RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting

International Journal of Pharmaceutics

Volumn 261, Issue 1-2, 2003, Pages 43-55

  Jain, Sanyog ^a   Mishra, Vivek ^a   Singh, Paramjit ^a   Dubey, P K ^a   Saraf, D K ^a   Vyas, S P ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Blood brain barrier; Brain targeting; Magnetic liposomes; Monocytes; Neutrophils; RGD

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CHOLESTEROL; CYANAMIDE; DICLOFENAC; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; RECOMBINANT INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CELL COUNT; BRAIN LEVEL; CELL SELECTION; CONTROLLED STUDY; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIVER; MAGNETISM; MALE; MONOCYTE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; STATISTICAL SIGNIFICANCE;

EID: 0043028168     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00269-2     Document Type: Article

References (46)

1. Anthony D.C., Bolton S.J., Fearn S., Perry V.H. Age related effects of interleukin-1β on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain. 120:1997;435-444.
2. Anthony D.C., Dempster R., Fearn S., Clements J., Wells G., Perry V.H., Walker K. CXC chemokines generate age-related increase in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr. Biol. 8:1998;923-926.
3. Aznavoorian S., Stracke M.L., Krutzsch H., Schiffmann E., Liotta L.A. Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells. J. Cell Biol. 110:1990;1427-1438.
4. Blamire A.M., Anthony D.C., Rajagopalan B., Sibson N.R., Perry V.H., Styles P. Interleukin-1 induced changes in blood-brain barrier permeability, apparent diffusion coefficient and cerebral blood volume in the rat brain: a magnetic resonance study. J. Neurosci. 20:2000;8153-8159.
5. Bolton S.J., Anthony D.C., Perry V.H. Loss of tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil induced blood brain barrier breakdown in vivo. Neuroscience. 86:1998;1245-1257.
6. Brightman M.W., Reese T.S. Junctions between intimately opposed cell membranes in the vertebrate brain. J. Cell Biol. 40:1969;649-677.
7. Eckert, R., Randall, D., Augustine, G., 1988. Animal Physiology Mechanisms and Adaptations, 3rd ed. W.H. Freeman, New York.
8. Gallo J.M., Gupta P.K., Hung C.T., Perrier D.G. Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat. J. Pharm. Sci. 78:1989;190-194.
9. Hauzenberger D., Klominek J., Sundqvist K.G. Functional specialization of fibronectin-binding beta 1-integrins in T lymphocyte migration. J. Immunol. 153:1993;960-971.
10. Hermanson, G.T., 1996. Bioconjugate Techniques. Academic Press, San Diego, California.
11. Huwyler J., Wu D., Pardridge W.M. Brain drug delivery of small molecules using immunoliposomes. Proc. Natl. Acad. Sci. U.S.A. 93:1996;14164-14169.
12. Jain S., Jain S., Singh P., Vyas S.P. New colorimetric method for estimation of magnetite in drug carrier systems. The Indian Pharmacist. 1:2002;74-76.
13. Jansons V.K., Mallett P.L. Targeted liposomes: a method for preparation and analysis. Anal. Biochem. 111:1980;54-59.
14. Juliano R.L., Stamp D. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem. Biophys. Res. Commun. 63:1975;651-658.
15. Kao W.J., Liu Y., Gundloori R., Li J., Lee D., Einerson N., Burmania J., Stevens K. Engineering endogenous inflammatory cells as delivery vehicle. J. Control. Rel. 78:2002;219-233.
16. Kirsh, R., Bugleski, P.J., Poste, G., 1987. Drug delivery to macrophages for the therapy of cancer and infectious diseases. In: Juliano, R.L. (Ed.), Biological Approaches to the Controlled Delivery of Drugs, The New York Academy of Sciences, New York, pp. 141-154.
17. Kiwada H., Sato J., Yamada S., Kato Y. Feasibility of magnetic liposomes as a targeting device for drugs. Chem. Pharm. Bull. 34:1986;4253-4258.
18. Kubo T., Sugita T., Shimose S., Nitta Y., Ikuta Y., Murakami T. Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters. Int. J. Oncol. 17:2000;309-315.
19. Kuby, J., 1994. Immunology, 2nd ed. W.H. Freeman and Co., New York.
20. Levinson, W.E., Jawetz, E., 1994. Medical Microbiology and Immunology, 3rd ed. Appleton and Lange, USA.
21. Martin, F.J., Heath, T.D., New, R.R.C., 1990. Covalent attachment of proteins to liposomes. In: New, R.R.C. (Ed.), Liposomes: A Practical Approach. Oxford University Press, Oxford, pp. 163-182.
22. Mora M., Sagrista M.L., Trombetta D., Bonina F.P., De Pasquale A., Saija A. Design and characterization of liposomes containing long-chain N-acylpes for brain delivery: penetration of liposomes incorporating GM1 into the rat brain. Pharm. Res. 19:2002;1430-1438.
23. New, R.R.C., 1990. Introduction and preparation of liposomes. In: New, R.R.C. (Ed.), Liposomes: A Practical Approach. Oxford University Press, Oxford, pp. 1-104.
24. Odekon L.E., Frewin M.B., Vecchio P.D., Saba T.M., Gudewicz P.W. Fibronectin fragments released from phorbol ester-stimulated pulmonary artery endothelial cell monolayers promote neutrophil chemotaxis. Immunology. 74:1991;114-120.
25. Perry V.H., Anthony D.C., Bolton S.J., Brown H.C. The blood-brain barrier and inflammatory response. Mol. Med. Today. 3:1997;335-341.
26. Perry V.H., Bell M.D., Brown H.C., Matyszak M.K. Inflammation in the nervous system. Curr. Opin. Neurobiol. 5:1995;636-641.
27. Poste G., Kirsch R., Fogler W.E., Fidler I.J. Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res. 42:1982;1412-1422.
28. Ranney, D.F., Huffaker, H.H., 1987. Magnetic microspheres for targeted controlled release of drugs and diagnostic agents. In: Juliano, R.L. (Ed.), Biological Approaches to the Controlled Delivery of Drugs. The New York Academy of Sciences, New York, pp. 104-119.
29. Rebasamen, E., Goldinger, W., Scheirer, W., Merten, O.W., Palfe, G.E., 1987. Developments in biological standardization. In: Spier, R., Hennessen, W. (Ed.), Advances in Animal Cell Technology and Cell Engineering: Evaluation and Exploitation, vol. 66. ESACT, Basel, pp. 273-278.
30. Reese T.S., Karnovsky M.J. Fine structural localization of a blood-brain barrier to exogeneous peroxidase. J. Cell Biol. 34:1967;207-217.
31. Sakamoto A., Ido T. Liposome targeting to rat brain: effect of osmotic opening of the blood-brain barrier. Brain Res. 629:1993;171-175.
32. Saiki I., Koike C., Obata A., Fuji H., Murata J., Kiso M., Hasegawa A., Komazawa H. Functional role of sialyl Lewis X and fibronectin derived RGDS peptide analogue on tumor cell arrest in lungs followed by extravasation. Int. J. Cancer. 65:1996;833-839.
33. Sayed E.L., Abdel-Hameed Y.M., Suleiman M.E., Najib N.M. Rapid and sensitive high performance liquid chromatographic method for determination of diclofenac sodium in serum and its use in pharmacokinetic studies. J. Pharm. Pharmacol. 40:1988;727-729.
34. Scherphof, G.L., 1991. In vivo behavior of liposomes. In: Juliano, R.L. (Ed.), Targeted Drug Delivery. Springer, Berlin, New York, pp. 285-300.
35. Senior R.M., Gresham H.D., Griffin G.L., Brown E.J., Chung A.E. Entactin stimulates neutrophil adhesion and chemotaxis through interactions between its Arg-Gly-Asp (RGD) domain and the leukocyte response integrin. J. Clin. Invest. 90:1992;2251-2257.
36. Shi N., Pardridge W.M. Noninvasive gene targeting to the brain. Proc. Natl. Acad. Sci. U.S.A. 97:2000;7567-7572.
37. Shi N., Zhang Y., Zhu C., Boado R.J., Pardridge W.M. Brain-specific expression of an exogenous gene after i.v. administration. Proc. Natl. Acad. Sci. U.S.A. 98:2001;12754-12759.
38. Shinkai M., Suzuki M., Iijima S., Kobayashi T. Antibody-conjugated magneto-liposomes for targeting cancer cells and their application in hyperthermia. Biotechnol. Appl. Biochem. 21:1995;125-137.
39. Shinkai M., Yanase M., Honda H., Wakabayashi T., Yoshida J., Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. Jpn. J. Cancer Res. 87:1996;1179-1183.
40. Szoka F. Jr., Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. U.S.A. 75:1978;4194-4198.
41. Thole M., Nobmanna S., Huwyler J., Bartmann A., Fricker G. Uptake of cationzied albumin coupled liposomes by cultured porcine brain microvessel endothelial cells and intact brain capillaries. J. Drug Target. 10:2002;337-344.
42. Umezawa F., Eto Y. Liposome targeting to mouse brain: mannose as a recognition marker. Biochem. Biophys. Res. Commun. 153:1988;1038-1044.
43. Viroonchatapan E., Ueno M., Sato H., Adachi I., Nagae H., Tazawa K., Horikoshi I. Preparation and characterization of dextran-magnetite incorporated thermosensitive liposomes: an on-line flow system for quantifying magnetic responsiveness. Pharm. Res. 12:1995;1176-1183.
44. Wang J.Y., Xu Y.R., Huang K., Sun L.Y. Proliposome targeting to rabbit brain tissue. J. Pharm. Pharmacol. 47:1995;1053-1054.
45. Yanase M., Shinkai M., Honda H., Wakabayashi T., Yoshida J., Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vivo study. Jpn. J. Cancer Res. 87:1996;1179-1183.
46. Zhang Y., Jeong Lee H., Boado R.J., Pardridge W.M. Receptor-mediated delivery of an antisense gene to human brain cancer cells. J. Gene Med. 4:2002;183-194.